Clinical trials
Phase 2 Carcinoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| Pfizer | 1 |
| Steba Biotech S.A. | 1 |
| dr. Tom van der Hulle | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 11 |
| Neoplasms | 5 |
| Adenocarcinoma | 2 |
| Carcinoma, Renal Cell | 2 |
| Neoplasms by Site | 2 |
| Neuroendocrine Tumors | 2 |
| Bronchial Neoplasms | 1 |
| Carcinoid Tumor | 1 |
| Carcinoma, Islet Cell | 1 |
| Carcinoma, Neuroendocrine | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.